
Following treatment, 17.5% and 13% of patients reported residual depressive and anxiety symptoms.

Following treatment, 17.5% and 13% of patients reported residual depressive and anxiety symptoms.

In addition, authors of a research letter noted that patients with vitiligo demonstrated a comparable risk of myocardial infarction and cerebrovascular accident.

Researchers found that the diameter of cutaneous melanoma demonstrated a weak positive correlation with tumor thickness.

The Harris brothers serve 2 predominantly elderly populations and appreciate the opportunity to provide solutions for the growing complexity of skin cancer issues as patients live longer.

Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month and Melanoma Monday.

Keep up with the latest headlines in dermatology from the past week, including the invention of a groundbreaking method for detecting skin cancer using Terahertz waves, a survey indicative of young people's perceptions of sun exposure, and more.

Robert Den, MD, and Alpha Tau are seeking motivated investigators who may be interested in participating in the trial.

Earlier this week, we shared our fourth and final Rosacea Awareness Month quiz. Review the answers and your responses below.

May is Mental Health Awareness Month, and Dermatology Times is spotlighting the common relationship between skin conditions and struggles with mental health, quality of life, and well-being.

A new review highlighted JAK inhibitors' role in vitiligo treatment, emphasizing varying benefits, facial efficacy, and potential for sustained responses.

This recap of skin cancer innovations accompanies the cover story of our May publication.

While 84% of commercials targeted female consumers and 77% utilized celebrity influence, less than half mentioned specific ingredients in skin lightening products.

Adalimumab-adbm is now approved for use in various indications, including psoriasis, psoriatic arthritis, and hidradenitis suppurativa.

Dermatology Times asked our readers to share what conferences they are looking forward to in the second quarter of 2024.

Learn more about the in-depth topics covered in the April 2024 print issue of Dermatology Times.

Dermatology Times is looking back on the top stories in dermatology from the month of April.

Dermatology Times is recapping our top expert interviews from the month of April.

A study found that in addition, recovery time was both quick and yielded minimal symptoms.

Click here to read more and answer our quiz questions in recognition of Rosacea Awareness Month.

Keep up with the latest headlines in dermatology from the past week, including the appointment of All Detergent's first chief dermatology advisor, Incyte's acquisition of Escient Pharmaceuticals, and more.

ICYMI, this week we had news about a study of upadacitinib versus dupilumab in atopic dermatitis, the European Union's approval of bimekizumab for HS, and more.

Skin cancer risk classification lacks reliability for darker skin tones and fails in evaluating cutaneous medical conditions or cosmetic interventions, according to creators of the scale.

Earlier this week, we shared our third Rosacea Awareness Month quiz. Review the answers and your responses below.

A cross-sectional study revealed an increase and heightened prevalence of Demodex and demodicosis in individuals with psoriasis receiving biologic therapy.

Researchers conducted a population-based study examining a sample of patients with HS during hospital admissions.

A review found that Mohs micrographic surgery and conventional excision yielded comparable patient reported outcomes.

At present, deployed members of the military are not permitted to be receiving therapy with systemic therapies such as immunomodulators and biologics.

The CRL indicates that the timing proposed for data submission would not allow enough time for the FDA to complete its review by the May 25 PDUFA date.

LC-OCT provided quick, noninvasive assessment of skin conditions with detailed imaging aids diagnosis and treatment, especially for patients with darker skin types.

This Earth Day, we are reviewing studies and research linking the role of the environment with various skin conditions.